Scalp Cooling for Hair Loss Control

We know that the prospect of losing your hair can be one of the scariest parts of facing chemotherapy.

Scalp cooling (aka cold capping) can help you retain your hair.

At the Burbage Regional Cancer Care Center, we recognize that hair loss can be one of the most traumatic side effects associated with chemotherapy. If this is a concern for you, know that there is a treatment option available to help you control hair loss and maintain your mental and emotional strength for the tough journey ahead.

Chemotherapy works by targeting all rapidly dividing cells in the body. Hair is the second fastest dividing cell, and this is the reason why many chemotherapy drugs cause hair loss. The hair follicles in the growth phase are attacked, resulting in hair loss about two weeks after beginning chemotherapy treatment.

The damage that chemotherapy causes to the hair follicle can be reduced by using scalp cooling treatment, also known as the 'cold cap.' It works by reducing the temperature of the scalp by a few degrees right before, during and after you receive chemotherapy.

Is Cold Capping Right for You?

Knowing if cold capping is right for you is something only you can decide. The information provided on this page will offer everything you need to know to be able to make an informed choice.

Download this Introduction Booklet for information about:

• How the Scalp Cooling technology works
• Who can use cold capping
• Who can’t use cold capping
• Possible side effects
• How much hair you can expect to keep
• Out-of-pocket cost
• Financial assistance options

Want to know more about the science behind cold capping? Click here for information and results of recent clinical studies.

The Long Term Benefits of Scalp Cooling

For more information about the Paxman Scalp Cooling treatment solution at the Burbage Regional Cancer Care Center, call 410-629-6888 or speak with a member of your cancer care team.

A special thanks to Jack Burbage for the donation that made this treatment possible for our patients.